The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Go back to The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
(NASDAQ: NTHI) Delayed: 3.45 +0.12 (3.60%)
Previous Close $3.33    52 Week High
Open $3.34    52 Week Low
Day High $3.45    P/E N/A 
Day Low $3.31    EPS
Volume 12,676